Largest pharmaceutical companies by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Pfizer leads the 61 pharmaceutical companies ranked by total assets, at NOK 2.02T, ahead of Johnson & Johnson (NOK 1.93T) and Sanofi (NOK 1.36T). Figures as of 18 Nov 2026, 19:59 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerNOK 2.02T
- Median
- NOK 34.2B
- Combined market value
- NOK 49.1T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | NOK 2.02T | NOK 1.55T | NOK 272.40 | 1.35% down | 14% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | NOK 1.93T | NOK 6.39T | NOK 2,652.76 | 1.86% down | 38% up | ||
| 3 | SanofiSNY · Health Care | NOK 1.36T | NOK 1.1T | NOK 457.94 | 0.66% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | NOK 1.33T | NOK 3.29T | NOK 1,335.45 | 3.96% down | 51% up | ||
| 5 | AbbVieABBV · Health Care | NOK 1.3T | NOK 4.9T | NOK 2,769.44 | 2.49% down | 26% up | ||
| 6 | AstraZenecaAZN · Health Care | NOK 1.11T | NOK 2.69T | NOK 1,733.01 | 1.97% down | 2% up | ||
| 7 | Eli LillyLLY · Health Care | NOK 1.09T | NOK 11.95T | NOK 13,415.73 | 2.28% down | 35% up | ||
| 8 | NovartisNVS · Health Care | NOK 1.08T | NOK 2.84T | NOK 1,504.02 | 2.55% down | 25% up | ||
| 9 | Takeda PharmaceuticalTAK · Health Care | NOK 942.2B | NOK 659.6B | NOK 206.44 | 1.64% down | 54% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | NOK 873.3B | NOK 1.19T | NOK 579.97 | 2.53% down | 34% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | NOK 841B | NOK 1.76T | NOK 1,015.00 | 0.06% down | 17% down | ||
| 12 | GSKGSK · Health Care | NOK 786.8B | NOK 946.6B | NOK 472.24 | 1.12% down | 6% up | ||
| 13 | Novo NordiskNVO · Health Care | NOK 781.4B | NOK 1.68T | NOK 382.28 | 3.16% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | NOK 395.2B | NOK 477.1B | NOK 408.86 | 1.09% down | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | NOK 393.4B | NOK 951B | NOK 9,192.76 | 1.04% down | 36% up | ||
| 16 | ViatrisVTRS · Health Care | NOK 360.7B | NOK 228.8B | NOK 199.56 | 0.61% up | 96% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | NOK 248.7B | NOK 1.32T | NOK 5,217.45 | 0.70% up | 27% up | ||
| 18 | GrifolsGRFS · Health Care | NOK 212.1B | NOK 55.6B | NOK 81.76 | 2.32% down | 1% up | ||
| 19 | Royalty PharmaRPRX · Health Care | NOK 190.3B | NOK 386.5B | NOK 672.23 | 0.92% up | 78% up | ||
| 20 | ZoetisZTS · Health Care | NOK 150B | NOK 338.6B | NOK 833.31 | 2.92% up | 29% down | ||
| 21 | Elanco Animal HealthELAN · Health Care | NOK 129.6B | NOK 130B | NOK 260.17 | 3.77% up | 20% up | ||
| 22 | GenmabGMAB · Health Care | NOK 124.9B | NOK 306.1B | NOK 496.39 | 1.50% down | 70% up | ||
| 23 | Jazz PharmaceuticalsJAZZ · Health Care | NOK 113.1B | NOK 153.9B | NOK 2,398.16 | 2.72% up | 37% up | ||
| 24 | BeOne MedicinesONC · Health Care | NOK 79.4B | NOK 448.1B | NOK 3,922.79 | 2.13% down | 17% up | ||
| 25 | United TherapeuticsUTHR · Health Care | NOK 76.4B | NOK 239.2B | NOK 5,617.53 | 0.84% down | 23% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | NOK 73.7B | NOK 115.1B | NOK 594.45 | 4.75% up | 11% up | ||
| 27 | Dr. Reddy's LaboratoriesRDY · Health Care | NOK 59.8B | NOK 121.2B | NOK 145.44 | 1.39% up | 5% up | ||
| 28 | Roivant SciencesROIV · Health Care | NOK 55.4B | NOK 271B | NOK 374.04 | 0.37% down | 90% up | ||
| 29 | Alnylam PharmaceuticalsALNY · Health Care | NOK 48.2B | NOK 192B | NOK 1,433.55 | 5.56% down | 66% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | NOK 35.7B | NOK 73.7B | NOK 211.63 | 3.31% up | 83% up | ||
| 31 | Ionis PharmaceuticalsIONS · Health Care | NOK 34.2B | NOK 45B | NOK 270.16 | 3.32% up | 64% down | ||
| 32 | PTC TherapeuticsPTCT · Health Care | NOK 28.1B | NOK 48.7B | NOK 583.34 | 0.36% down | 20% down | ||
| 33 | AlkermesALKS · Health Care | NOK 24.1B | NOK 75.5B | NOK 449.45 | 1.96% up | 58% up | ||
| 34 | InsmedINSM · Health Care | NOK 22B | NOK 255.7B | NOK 1,165.67 | 1.37% down | 40% down | ||
| 35 | Legend BiotechLEGN · Health Care | NOK 16.8B | NOK 30.5B | NOK 157.17 | 0.59% up | 42% down | ||
| 36 | Ligand PharmaceuticalsLGND · Health Care | NOK 15.1B | NOK 58B | NOK 2,901.93 | 1.83% up | 43% up | ||
| 37 | Ascendis PharmaASND · Health Care | NOK 14B | NOK 172.4B | NOK 2,627.93 | 0.09% down | 28% up | ||
| 38 | CytokineticsCYTK · Health Care | NOK 13.8B | NOK 69.4B | NOK 498.53 | 0.48% down | 20% down | ||
| 39 | Arrowhead PharmaceuticalsARWR · Health Care | NOK 13.4B | NOK 59.5B | NOK 420.84 | 0.93% up | 10% up | ||
| 40 | Madrigal PharmaceuticalsMDGL · Health Care | NOK 12.2B | NOK 90.8B | NOK 3,909.31 | 4.48% down | 24% down | ||
| 41 | TG TherapeuticsTGTX · Health Care | NOK 10.3B | NOK 96.4B | NOK 637.61 | 4.83% up | 107% up | ||
| 42 | Praxis Precision MedicinesPRAX · Health Care | NOK 9.1B | NOK 83.1B | NOK 2,971.66 | 0.44% up | 61% up | ||
| 43 | Cogent BiosciencesCOGT · Health Care | NOK 9.1B | NOK 47.3B | NOK 272.10 | 0.74% up | 20% down | ||
| 44 | BridgeBio PharmaBBIO · Health Care | NOK 9.1B | NOK 147.3B | NOK 756.03 | 1.50% up | 17% up | ||
| 45 | Mirum PharmaceuticalsMIRM · Health Care | NOK 8.2B | NOK 58.8B | NOK 901.03 | 1.03% up | 31% up | ||
| 46 | Corcept TherapeuticsCORT · Health Care | NOK 8.1B | NOK 72.2B | NOK 659.48 | 2.96% down | 8% down | ||
| 47 | Belite BioBLTE · Health Care | NOK 7.6B | NOK 61.3B | NOK 1,509.21 | 1.34% down | 31% up | ||
| 48 | Spyre TherapeuticsSYRE · Health Care | NOK 7.5B | NOK 92.9B | NOK 977.85 | 7.47% up | 286% up | ||
| 49 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | NOK 7.4B | NOK 72.4B | NOK 921.69 | 0.08% down | 126% up | ||
| 50 | Summit TherapeuticsSMMT · Health Care | NOK 7.3B | NOK 81.4B | NOK 101.79 | 1.64% down | 36% down | ||
| 51 | Axsome TherapeuticsAXSM · Health Care | NOK 6.7B | NOK 68.5B | NOK 1,301.70 | 1.28% down | 7% down | ||
| 52 | Protagonist TherapeuticsPTGX · Health Care | NOK 6.5B | NOK 80.2B | NOK 1,227.98 | 1.56% up | 46% up | ||
| 53 | ABIVAXABVX · Health Care | NOK 6.3B | NOK 71B | NOK 810.88 | 1.83% up | 27% down | ||
| 54 | Travere TherapeuticsTVTX · Health Care | NOK 5.9B | NOK 47.1B | NOK 490.23 | 1.09% down | 44% up | ||
| 55 | Edgewise TherapeuticsEWTX · Health Care | NOK 5.4B | NOK 44B | NOK 401.73 | 1.47% down | 88% up | ||
| 56 | Dianthus TherapeuticsDNTH · Health Care | NOK 5.1B | NOK 46.4B | NOK 824.02 | 2.32% down | 113% up | ||
| 57 | Oruka TherapeuticsORKA · Health Care | NOK 4.7B | NOK 62.9B | NOK 927.90 | 0.67% down | 241% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | NOK 4.7B | NOK 80B | NOK 1,154.15 | 2.05% up | 13% up | ||
| 59 | Definium TherapeuticsDFTX · Health Care | NOK 4.3B | NOK 38.2B | NOK 279.04 | 2.08% down | 169% up | ||
| 60 | ErascaERAS · Health Care | NOK 3.8B | NOK 46B | NOK 131.13 | 2.66% down | 403% up | ||
| 61 | VeradermicsMANE · Health Care | NOK 1.5B | NOK 51.1B | NOK 1,210.53 | 0.66% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 9.6989 NOK).
Questions and answers
Which pharmaceutical companies rank first by total assets?
Pfizer (NOK 2.02T), Johnson & Johnson (NOK 1.93T) and Sanofi (NOK 1.36T) are the top three of the 61 pharmaceutical companies ranked by total assets as of 18 Nov 2026, 19:59 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by total assets.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by total assets have a combined market value of NOK 49.1T as of 18 Nov 2026, 19:59 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.